Ani pharmaceuticals inc

Major-Pharmaceuticals

ANIP


210 Main Street West
Baudette , MN 56623

Executive/
Director

Price

  • Last Close
  • $ 56.04
    $ -0.82 -1.44 %
    Dec 5, 2024
  • 52-Week High/Low
  • $70.08 - $48.72
  • YTD
  • 1.6%

  • Trading Volume
  • 11,114
  • Market Cap Full
  • $ 1.4B
  • Shares Outstanding
  • 24.4M
    Feb 28, 2013
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 10.9% -25.4% -18.3% -9.7% 56.7% -5% 24.5% -35.6% -1.3% 25.4%
Q2 -0.8% 65.8% -5.5% 18.5% 14.1% 4% -3% 0% 35.5% -1.7%
Q3 -36.3% 18.9% 12.2% -16.7% -11.2% 8% -6.4% 8.3% 7.9% -
Q4 14.2% -8.6% 18.6% -19.8% -17.2% 2.9% 40.4% 25.2% -3% -
J F M A M J J A S O N D
2024 1.2% 21.2% 2.2% -3.5% - - - - - - - -
2023 11.2% -6.5% -5.1% -5% 19.7% 19.3% -2.4% 22.5% -9.8% 6.3% -19.3% 10.7%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    181%-20%34%6%-30%35%-52%59%-13%37%2%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.53 0.66 0.62 0.19 0.04 -0.59 0.01 -1.27 0.06
Q2 0.31 0.99 0.88 0.23 0.53 -1.03 -1.17 -0.94 0.29
Q3 0.39 1.02 1.03 0.42 0.32 0.04 -0.37 -0.55 0.45
Q4 0.43 0.82 1 0.46 -0.39 -0.3 -1.87 -0.29 -
A 1.7 3.5 3.5 1.3 0.5 -1.9 -3.4 -3.1 0.8

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Mar
Jun
Sep
Dec

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1.3 1.2 1.4 1.3 1.8
Fixed Asset Turnover 5.9 3.6 4.4 4.4 4.6
Total Asset Turnover 0.4 0.3 0.5 0.5 0.5
Leverage
Debt Ratio 0.8 0.9 1 0.9 0.4
Debt – Equity Ratio 0.8 0.8 0.9 0.8 0.3
Interest Coverage -2.7 -13.3 -2.3 1.6 1.8
Equity multiplier 0.2 0.2 0.2 0.2 0.2